Anti HER-2 therapies and left ventricular dysfunction: A prospective study
Andrés J. Daniele(Asociación por los Derechos Civiles), Vanesa Gregorietti
Cited by 0
Related Papers
Cardiovascular Manifestations From Therapeutic Radiation
|JACC CardioOncology|2021|201
Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
|Cardio-Oncology|2020|59
Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial
|Cardio-Oncology|2024|32
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey
|Cardio-Oncology|2020|28
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
|Current Oncology Reports|2021|19